Therapeutically, chronic actinic dermatitis is a problematic condition. Frequently applied sunscreen usually fails to mitigate the clinical symptoms, and steroids – while efficient – exert many undesired side-effects with prolonged usage. We present a case of chronic actinic dermatitis responding well to topically applied tacrolimus (Protopic®) in combination with chemical and physical UV protection.

1.
Dummer R, Ivanova K, Scheidegger EP, Burg G: Clinical and therapeutic aspects of polymorphous light eruption. Dermatology 2003;207:93–95.
2.
Waldmann V, Kempf W, Burg G, Dummer R: Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid. Hautarzt 1997;48:262–265.
3.
Kikuchi K, Tagami H: Comparison of the effects of daily applications between topical corticosteroid and tacrolimus ointments on normal skin: Evaluation with non-invasive methods. Dermatology 2002;205:378–382.
4.
Böhm M, Gaubitz M, Luger TA, Metze D, Bonsmann G: Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. Dermatology 2003;207:381–385.
5.
Wenzel J, Gerdsen R, Philipp-Dormston W, Bieber T, Uerlich M: Topical treatment of pyoderma gangraenosum. Dermatology 2002;205:221–223.
6.
Meyer JC, Hassam S, Dummer R, Muletta S, Dobbeling U, Dommann SN, Burg G: A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol 1997;3:122–127.
7.
Uetsu N, Okamoto H, Fujii K, Doi R, Horio T: Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol 2002;47:881–884.
8.
Suga Y, Hashimoto Y, Matsuba S, Mizoguchi M, Ogawa H: Topical tacrolimus for chronic actinic dermatitis. J Am Acad Dermatol 2002;46:321–323.
9.
Abe R, Shimizu T, Tsuji A, Matsumura T, Shimizu H: Severe refractory chronic actinic dermatitis successfully treated with tacrolimus ointment. Br J Dermatol 2002;147:1273–1275.
10.
Wilkinson DS: Photodermatitis due to tetrachlorsalicylanilide. Br J Dermatol 1961;73:213–219.
11.
Ive FA, Magnus IA, Warin RP, Jones EW: ‘Actinic reticuloid’; a chronic dermatosis associated with severe photosensitivity and the histological resemblance to lymphoma. Br J Dermatol 1969;81:469–485.
12.
Hawk JL, Magnus IA: Chronic actinic dermatitis – An idiopathic photosensitivity syndrome including actinic reticuloid and photosensitive eczema. Br J Dermatol 1979;101(suppl 17):24.
13.
Murphy GM, Maurice PD, Norris PG, Morris RW, Hawk JL: Azathioprine treatment in chronic actinic dermatitis: A double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 1989;121:639–646.
14.
Hindson C, Spiro J, Downey A: PUVA therapy of chronic actinic dermatitis. Br J Dermatol 1985;113:157–160.
15.
Stinco G, Codutti R, Frattasio A, De Francesco V, Patrone P: Chronic actinic dermatitis treated with cyclosporine-A. Eur J Dermatol 2002;12:455–457.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.